• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.

作者信息

Tanaka Mayumi, Isogai Emiko, Isogai Hiroshi, Hayashi Shunji, Hirose Kimiharu, Kimura Koichi, Sugiyama Toshiro, Sato Kenichi

出版信息

J Antimicrob Chemother. 2002 Jun;49(6):1039-40. doi: 10.1093/jac/dkf055.

DOI:10.1093/jac/dkf055
PMID:12039901
Abstract
摘要

相似文献

1
Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.喹诺酮类抗菌药物与质子泵抑制剂对幽门螺杆菌的协同作用。
J Antimicrob Chemother. 2002 Jun;49(6):1039-40. doi: 10.1093/jac/dkf055.
2
New quinolone compounds from Pseudonocardia sp. with selective and potent anti-Helicobacter pylori activity: taxonomy of producing strain, fermentation, isolation, structural elucidation and biological activities.来自假诺卡氏菌属的具有选择性强效抗幽门螺杆菌活性的新型喹诺酮化合物：产生菌的分类学、发酵、分离、结构解析及生物学活性
J Antibiot (Tokyo). 1998 Feb;51(2):145-52. doi: 10.7164/antibiotics.51.145.
3
In vitro activities of new quinolones against Helicobacter pylori.新型喹诺酮类药物对幽门螺杆菌的体外活性
Antimicrob Agents Chemother. 1997 Dec;41(12):2790-2. doi: 10.1128/AAC.41.12.2790.
4
Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.质子泵抑制剂与抗生素对幽门螺杆菌的体外杀菌活性及协同作用研究
J Antimicrob Chemother. 1997 Mar;39(3):331-7. doi: 10.1093/jac/39.3.331.
5
In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori.
J Antimicrob Chemother. 2002 Oct;50(4):547-52. doi: 10.1093/jac/dkf159.
6
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.7-(2-氨基烷基)吗啉代喹诺酮类作为抗幽门螺杆菌药物的合成及构效关系
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2185-90. doi: 10.1016/s0960-894x(98)00390-4.
7
Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae fructus.
Biol Pharm Bull. 1999 Oct;22(10):1141-3. doi: 10.1248/bpb.22.1141.
8
Drug resistance of Helicobacter pylori: memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter, and Related Organisms.
J Infect Dis. 1992 May;165(5):974-5. doi: 10.1093/infdis/165.5.974.
9
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.大环内酯类药物与质子泵抑制剂对幽门螺杆菌的协同相互作用：一项体外比较研究。
J Antimicrob Chemother. 1998 Mar;41 Suppl B:29-35. doi: 10.1093/jac/41.suppl_2.29.
10
[Helicobacter pylori: what schemes of eradication are essential today?].[幽门螺杆菌：当今哪些根除方案至关重要？]
Ter Arkh. 2011;83(8):41-4.

引用本文的文献

1
Armeniaspirol A: a novel anti-Helicobacter pylori agent.亚美尼亚螺旋霉素 A：一种新型抗幽门螺杆菌药物。
Microb Biotechnol. 2022 Feb;15(2):442-454. doi: 10.1111/1751-7915.13807. Epub 2021 Mar 29.
2
Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori and .二氢丹参酮 I 可有效对抗耐药性幽门螺杆菌。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01921-20.
3
Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of in Peptic Ulcer Disease.基于左氧氟沙星的三线疗法根除消化性溃疡疾病中幽门螺杆菌的疗效。 （你原文中“of the Eradication of in Peptic Ulcer Disease”这里少了个关键单词，比如“Helicobacter pylori”之类的，我按照常见情况补充完整翻译了，你可根据实际情况调整）
Gut Liver. 2017 Mar 15;11(2):226-231. doi: 10.5009/gnl16099.
4
A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.一项比较两种含左氧氟沙星的二线疗法根除幽门螺杆菌的随机对照试验。
Medicine (Baltimore). 2016 May;95(19):e3586. doi: 10.1097/MD.0000000000003586.
5
Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial.克拉霉素与吉米沙星用于幽门螺杆菌感染经验性初始治疗的四联疗法：一项随机临床试验
Middle East J Dig Dis. 2015 Apr;7(2):88-93.
6
Quinolone-containing therapies in the eradication of Helicobacter pylori.含喹诺酮类药物的疗法用于根除幽门螺杆菌。
Biomed Res Int. 2014;2014:151543. doi: 10.1155/2014/151543. Epub 2014 Aug 28.
7
The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication.二线根除幽门螺杆菌时含左氧氟沙星三联疗法优化的临床及细菌学因素。
PLoS One. 2014 Aug 20;9(8):e105822. doi: 10.1371/journal.pone.0105822. eCollection 2014.
8
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan.台湾地区二线抗幽门螺杆菌治疗中含左氧氟沙星的 10 天与 14 天三联疗法比较。
Gastroenterol Res Pract. 2013;2013:932478. doi: 10.1155/2013/932478. Epub 2013 Oct 22.
9
Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.使用埃索美拉唑和阿莫西林作为幽门螺杆菌感染三线挽救治疗的双联疗法试验。
Clin Endosc. 2011 Sep;44(1):33-7. doi: 10.5946/ce.2011.44.1.33. Epub 2011 Sep 30.
10
Rescue Therapy for Helicobacter pylori Infection 2012.2012 年幽门螺杆菌感染的挽救治疗。
Gastroenterol Res Pract. 2012;2012:974594. doi: 10.1155/2012/974594. Epub 2012 Feb 28.